XRHealth buys PursueCare, adding clinician-led addiction care to its digital platform
What's the deal? XRHealth, a platform for therapeutic technologies, has acquired PursueCare, a virtual provider of addiction treatment for alcohol, opioids, cannabis, and co-occurring mental health conditions. The deal, announced in November 2026, includes PursueCare's telehealth clinical services and its FDA-authorized prescription digital therapeutics, RESET and RESET-O. The purchase price was not disclosed.
What each side brings: PursueCare connects patients with licensed addiction clinicians, therapists, psychiatrists, and case managers through a smartphone app. XRHealth adds its technology-driven approach to personalized care across AR and VR glasses, smartphones, smartwatches, and other devices.
Why now? In 2025, 44.6 million Americans aged 12 or older had a substance use disorder, and 89% received no treatment, according to a SAMHSA national survey. Provider shortages, stigma, and cost make care hard to sustain.
What's the endgame? The acquisition extends XRHealth's bid to build what it calls a connected healthcare ecosystem. The company has been assembling that platform through deals: it bought RealizedCare in 2025, InnerworldDealroom has a profile for this one. Try Dealroom → in late 2025, and Swing Therapeutics in 2026, adding behavioral-health, peer-support, and prescription digital-therapy capabilities. PursueCare pushes it into clinician-led addiction care.
"Substance use disorders require care that is personalized, continuous, and accessible, yet too often patients face barriers to receiving the right support at the right time," said Eran Orr, founder and chief executive officer of XRHealth. He said the deal combines PursueCare's expertise in virtual addiction treatment with XRHealth's technology, letting patients "access care at the exact moment of need to prevent a further relapse."
What changes for patients? PursueCare's model combines medical care, behavioral health, medications, and software-based treatments. Services can include medications for opioid use disorder, therapy, psychiatric care, and case management covering transitions from hospitals and prisons, plus referrals for housing, transportation, and food security.
The acquired RESET and RESET-O programs deliver cognitive behavioral therapy and contingency management through a smartphone. RESET is indicated to increase abstinence and treatment retention in adults with substance use disorder; RESET-O targets retention in outpatient treatment for opioid use disorder.
The signal: The timing fits a market where virtual addiction providers are adding wraparound support — Ria Health recently partnered with CHESS HealthDealroom has a profile for this one. Try Dealroom → for round-the-clock peer support. The deal matters less as a standalone transaction than as XRHealth's effort to fuse digital tools with clinical services across conditions; whether that integration improves reach or outcomes remains to be shown.
Read more: prweb.com
Image credit: Generated with Gemini